TY - JOUR T1 - Thyroid Follicular Epithelial Cell–Derived Cancer: New Approaches and Treatment Strategies JF - Journal of Nuclear Medicine Technology JO - J. Nucl. Med. Technol. SP - 199 LP - 208 DO - 10.2967/jnmt.120.257105 VL - 49 IS - 3 AU - Julie Bolin Y1 - 2021/09/01 UR - http://tech.snmjournals.org/content/49/3/199.abstract N2 - Thyroid follicular epithelial cell–derived cancer includes papillary carcinoma, follicular carcinoma, Hürthle cell carcinoma, poorly differentiated thyroid cancer, and anaplastic thyroid carcinoma. Although the incidence of thyroid cancer has increased over the past 30 years, there has not been a significant increase in patient mortality. Use of increasingly sensitive detection methods such as high-resolution imaging has enabled earlier detection and better characterization of the thyroid malignancies. In the past several years, researchers have evaluated genetic mutations promoting thyroid carcinogenesis and oncogenesis. The identification of genetic mutations is important in understanding tumor initiation and progression. Additionally, these identified mutations may also serve as potential diagnostic or prognostic indicators and therapeutic molecular targets. ER -